stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +10.2%
- EPS
- +450.0%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to June 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Free cash flow
Elanco Animal Health Incorporated's free cash flow for fiscal 2025 was $284.0M, down 25.3% from $380.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $379.0M. Over the past ten years it has ranged from −$280.0M (fiscal 2020) to $380.0M (fiscal 2024); the current reading is higher than 64% of that period. Elanco Animal Health Incorporated ranks 9th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $284.0M | (25.26%) |
| FY2024 | $380.0M | 224.79% |
| FY2023 | $117.0M | (56.34%) |
| FY2022 | $268.0M | (6.29%) |
| FY2021 | $286.0M | — |
| FY2020 | −$280.0M | — |
| FY2019 | $27.0M | (92.50%) |
| FY2018 | $360.2M | 281.97% |
| FY2017 | $94.3M | 77.92% |
| FY2016 | $53.0M | (84.26%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $244.0M | — |
| Mar 2026 | −$38.0M | — |
| Dec 2025 | $46.0M | (63.78%) |
| Sep 2025 | $127.0M | (29.44%) |
| 34 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| VTRS Viatris Inc. compare | $2.4B |
| NBIX Neurocrine Biosciences, Inc. compare | $1.0B |
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| ELAN Elanco Animal Health Incorporated | $379.0M |
| ALKS Alkermes plc compare | $228.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $197.2M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement